Ligand Pharmaceuticals
LGND
#2741
Rank
NZ$11.20 B
Marketcap
NZ$560.34
Share price
0.00%
Change (1 day)
51.10%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): NZ$0.10 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2025 the company made an earning of NZ$0.29 Billion, an increase over its 2024 earnings that were of NZ$9.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.10 B-63.93%
2025 NZ$0.29 B2848.57%
2024 NZ$9.9 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.11 B296.42%
2020 NZ$30.11 M-97.97%
2019 NZ$1.48 B275.62%
2018 NZ$0.39 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$78.57 M55.41%
2015 NZ$50.55 M36.87%
2014 NZ$36.94 M29.59%
2013 NZ$28.5 M1309.35%
2012 NZ$2.02 M-43.97%
2011 NZ$3.61 M-113.19%
2010 -NZ$27.37 Million59.86%
2009 -NZ$17.13 Million-61.33%
2008 -NZ$44.28 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$89.06 Million81.27%
2005 -NZ$49.13 Million
2003 -NZ$34.21 Million-20.6%
2002 -NZ$43.08 Million4.38%
2001 -NZ$41.27 Million-48.83%
2000 -NZ$80.65 Million-19.74%
1999 -NZ$0.11 Billion-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$54.76 Million-5.83%
1996 -NZ$58.15 Million136.23%
1995 -NZ$24.62 Million-33.97%
1994 -NZ$37.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.39 B 30,636.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.42 B 11,340.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$62.01 B 56,983.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$19.71 B 18,045.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.34 Billion-407.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$11.99 B 10,937.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.21 B 18,504.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$12.76 B 11,646.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.12 Billion-201.60%๐Ÿ‡บ๐Ÿ‡ธ USA